Injectable placenta extract for fatty liver disease
Part of Digestive system clinical trials.
This trial tests an injectable medication made from human placenta to see if it can improve liver health in people with fatty liver disease (from alcohol or other causes). It may help lower liver enzyme levels and reduce liver damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 70 years old.
- You have been diagnosed with alcoholic fatty liver disease or non-alcoholic fatty liver disease.
- Your ALT level (a liver enzyme test) is between 60 and 200 IU/L.
- You have not had serious liver problems (like bleeding from the esophagus, fluid buildup, or liver cancer) in the past year.
- You do not have hepatitis B or C (unless treated successfully), or other active infections like tuberculosis.
- You agree to avoid certain medications and alcohol during the trial, and use effective birth control if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a treatment called plasmapheresis (plasma exchange) can help people with severe liver damage caused by medications when they also have chronic liver disease. The treatment filters the blood to remove harmful substances, which may improve liver function and recovery.
This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.
This trial tests whether a probiotic supplement can improve liver health and metabolism in adults with early signs of fatty liver or related conditions. It may help reduce fat in the liver and improve blood sugar and blood pressure.
This study tests whether a new drug called AZD2389 is safe and well-tolerated in adults with steatotic liver disease (fatty liver) that has progressed to advanced scarring. The trial aims to see if this drug might help slow or improve liver damage in people with this condition.
This trial tests special food products made from plant protein to see if they are well-tolerated and if they can improve your cholesterol and fat levels in the blood. If you have fatty liver disease, this could be a way to improve your health through diet.
This trial tests if hydroxychloroquine, a medicine used for other conditions, can reduce liver inflammation in people with fatty liver disease. It aims to help those whose fatty liver has caused ongoing liver damage.
Hear when a new Chronic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.